Limits...
The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.

Blood PA, Pickles T - Radiat Oncol (2007)

Bottom Line: The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer.Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment.This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

View Article: PubMed Central - HTML - PubMed

Affiliation: Radiation Oncology, BC Cancer Agency and University of British Columbia, Victoria, BC, Canada. pblood@bccancer.bc.ca

ABSTRACT
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

Show MeSH

Related in: MedlinePlus

Kaplan-Meier survival functions. The top curve is prostate specific survival, the middle curve is non-prostate cancer survival and the bottom curve is all-cause survival.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC1887532&req=5

Figure 1: Kaplan-Meier survival functions. The top curve is prostate specific survival, the middle curve is non-prostate cancer survival and the bottom curve is all-cause survival.

Mentions: Figure 1 shows the Kaplan-Meier (K-M) survival curves for deaths from prostate cancer, non-prostate cancer deaths, and deaths from all causes. Survival is measured from the start date of radiation treatment. The K-M prostate cancer survival censors deaths from non-prostate cancer and men who are still alive at the end of the study period. The K-M non-prostate cancer survival censors deaths from prostate cancer and men who are still alive at the end of the study period.


The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.

Blood PA, Pickles T - Radiat Oncol (2007)

Kaplan-Meier survival functions. The top curve is prostate specific survival, the middle curve is non-prostate cancer survival and the bottom curve is all-cause survival.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC1887532&req=5

Figure 1: Kaplan-Meier survival functions. The top curve is prostate specific survival, the middle curve is non-prostate cancer survival and the bottom curve is all-cause survival.
Mentions: Figure 1 shows the Kaplan-Meier (K-M) survival curves for deaths from prostate cancer, non-prostate cancer deaths, and deaths from all causes. Survival is measured from the start date of radiation treatment. The K-M prostate cancer survival censors deaths from non-prostate cancer and men who are still alive at the end of the study period. The K-M non-prostate cancer survival censors deaths from prostate cancer and men who are still alive at the end of the study period.

Bottom Line: The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer.Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment.This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

View Article: PubMed Central - HTML - PubMed

Affiliation: Radiation Oncology, BC Cancer Agency and University of British Columbia, Victoria, BC, Canada. pblood@bccancer.bc.ca

ABSTRACT
Treatment guidelines recommend that curative radiation treatment of prostate cancer be offered only to men whose life expectancy is greater than 10 years. The average life expectancy of North American males is less than 10 years after age 75, yet many men older than 75 years receive curative radiation treatment for prostate cancer. This study used the provincial cancer registry in British Columbia, Canada, to determine median non-prostate cancer survival for men who were aged 75 to 82 years at start of radiation treatment. Median survival was found to be greater than 10 years in men aged up to 80 years at the start of their radiation treatment. This finding suggests that radiation oncologists are able to appropriately select elderly men with greater than average life expectancy to receive curative radiation treatment.

Show MeSH
Related in: MedlinePlus